These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 14255170)
1. THE USE OF DRUGS IN THE TREATMENT OF IRREVERSIBLE VASOCONSTRICTOR SHOCK. FITTS CT; SAWYER RB J Trauma; 1965 Jan; 5():11-5. PubMed ID: 14255170 [No Abstract] [Full Text] [Related]
2. THE NATURE OF IRREVERSIBLE SHOCK: EXPERIMENTAL AND CLINICAL OBSERVATIONS. LILLEHEI RC; LONGERBEAM JK; BLOCH JH; MANAX WG Ann Surg; 1964 Oct; 160(4):682-710. PubMed ID: 14210369 [No Abstract] [Full Text] [Related]
3. REGIONAL BLOOD FLOW ALTERATIONS. STUDIES OF CHANGES IN THIS COURSE PRODUCED BY A VASOCONSTRICTOR AND AN ADRENERGIC BLOCKING AGENT DURING READJUSTMENT TO HEMORRHAGIC SHOCK. POLLOCK L; KJARTANSSON KB; DELIN NA; SCHENK WG Arch Surg; 1964 Aug; 89():344-54. PubMed ID: 14160163 [No Abstract] [Full Text] [Related]
4. THE MANAGEMENT OF EXPERIMENTAL ENDOTOXIN SHOCK. THE CIRCULATORY EFFECTS OF LEVARTERENOL, HYDROCORTISONE, PHENOXYBENZAMINE HYDROCHLORIDE, AND BLOOD VOLUME EXPANSION. SMITH LL; MULLER W; HINSHAW DB Arch Surg; 1964 Oct; 89():630-6. PubMed ID: 14186793 [No Abstract] [Full Text] [Related]
5. [RESUSCITATION IN SEVERE SHOCK-COLLAPSE STATES. (ASSOCIATION OF AN ADRENOCORTICAL VASOPRESSOR MIXTURE WITH SYMPATHOLYTICS OR NEUROPLEGICS)]. MANDACHE F; PRODESCO V; MATEESCO D; KOEVER G; MATEICA M; CANTAGARIU S; STANCIULESCO P Agressologie; 1964; 5():385-96. PubMed ID: 14189607 [No Abstract] [Full Text] [Related]
6. THE EFFECT OF ENDOTOXIN AND VASOACTIVE AGENTS ON DIBENZYLINE-PRETREATED LUNGS. SUKHNANDAN R; THAL AP Surgery; 1965 Jul; 58():185-96. PubMed ID: 14305153 [No Abstract] [Full Text] [Related]
7. HEMODYNAMIC ACTION OF VASOPRESSOR AND VASODEPRESSOR AGENTS IN ENDOTOXIN SHOCK. MORRIS JA; SMITH RW; ASSALI NS Am J Obstet Gynecol; 1965 Feb; 91():491-503. PubMed ID: 14259138 [No Abstract] [Full Text] [Related]
8. THE MODERN TREATMENT OF SHOCK BASED ON PHYSIOLOGIC PRINCIPLES. LILLEHEI RC; LONGERBEAM JK; BLOCH JH; MANAX WG Clin Pharmacol Ther; 1964; 5():63-101. PubMed ID: 14107123 [No Abstract] [Full Text] [Related]
9. ALTERATION OF VASCULAR RESPONSES TO ENDOTOXIN BY ADRENERGIC BLOCKADE. BRAKE CM; EMERSON TE; WITTMERS LE; HINSHAW LB Am J Physiol; 1964 Jul; 207():149-51. PubMed ID: 14193579 [No Abstract] [Full Text] [Related]
11. THE INFLUENCE OF LOW MOLECULAR WEIGHT DEXTRAN ON LETHAL ENDOTOXEMIA. O'NEILL JA; FOSTER JH Am Surg; 1964 Sep; 30():612-6. PubMed ID: 14209705 [No Abstract] [Full Text] [Related]
12. THE NATURE OF EXPERIMENTAL IRREVERSIBLE SHOCK WITH ITS CLINICAL APPLICATION. LILLEHEI RC; LONGERBEAM JK; BLOCH JH; MANAX WG Int Anesthesiol Clin; 1964 Feb; 2():297-363. PubMed ID: 14125015 [No Abstract] [Full Text] [Related]
13. OXYGEN DEFICIT AND IRREVERSIBLE HEMORRHAGIC SHOCK. CROWELL JW; SMITH EE Am J Physiol; 1964 Feb; 206():313-6. PubMed ID: 14120433 [No Abstract] [Full Text] [Related]
14. PHYSIOLOGY AND THERAPY OF BACTEREMIC SHOCK. EXPERIMENTAL AND CLINICAL OBSERVATIONS. LILLEHEI RC; LONGERBEAM JK; BLOCH JH Am J Cardiol; 1963 Nov; 12():599-613. PubMed ID: 14075985 [No Abstract] [Full Text] [Related]
15. EFFECTS OF VASOPRESSORS AND BLOCKING AGENTS ON THE KIDNEY IN OLIGEMIA. GIOJUBS RW; SIMEONE FA Surg Forum; 1964; 15():12-3. PubMed ID: 14189284 [No Abstract] [Full Text] [Related]
16. QUANTITATIVE STUDY OF INTESTINAL FLUID LOSS IN IRREVERSIBLE HEMORRHAGIC SHOCK. PORCIUNCULA CI; CROWELL JW Am J Physiol; 1963 Aug; 205():261-3. PubMed ID: 14058097 [No Abstract] [Full Text] [Related]
17. HEMODYNAMIC EFFECTS OF VASOPRESSOR AGENTS IN HEMORRHAGIC SHOCK. MILLS LC; STEPPACHER R Am J Cardiol; 1963 Nov; 12():614-8. PubMed ID: 14075986 [No Abstract] [Full Text] [Related]